Lv6
1740 积分 2024-02-27 加入
Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS)
28天前
已完结
Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI
2个月前
已完结
Schizophrenia: Genetics, neurological mechanisms, and therapeutic approaches
2个月前
已完结
Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open‐Label Study
3个月前
已完结
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
5个月前
已完结
Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
1年前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
1年前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
1年前
已完结
皖公网安备34019202002308
